FDA’s feedback supports the initiation of the Phase III trialAgitation-Aggression in Borderline Personality Disorder (BPD) acknowledged as a possible therapeutic indicationOryzon may use STAXI-2 Trait ...
(IN BRIEF) Alma Media has sold its 65% stake in Kotikokki Net Oy to Rohea Oy, which already owned a minority share of the company. The sale will be finalized on October 1, 2024. Kotikokki.net is a ...